glp-1 review article receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Dual GIP/GLP-1 receptor agonists: New
Description
Obesity (Silver Spring) 2022 Jul
Diabetes Care 43 , 28592869 (2020)
Mary Newport shares how she used coconut oil, MCT oil, and ketogenic strategies to help her husband with early-onset Alzheimers disease
GLP-1 medications demonstrates notable differences in their modes of action
This is especially helpful for people who dont want to use an injectable medicine to keep their blood sugar under control
